Structures by: Alsubari A.

Total: 4

3-[2-(5<i>H</i>-Indolo[2,3-<i>b</i>]quinoxalin-5-yl)ethyl]-1,3-oxazolidin-2-one

C19H16N4O2

Alsubari, AbdussalamBouhfid, RachidZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 9 o2461

a=14.5565(4)Å   b=5.8993(2)Å   c=18.6434(6)Å

α=90.00°   β=92.393(2)°   γ=90.00°

<i>N</i>'-(1-Allyl-2-oxoindolin-3-ylidene)benzohydrazide

C18H15N3O2

Alsubari, AbdulsalamMoussaif, AhmedZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 8 o1905

a=7.5921(2)Å   b=15.1968(4)Å   c=12.8716(3)Å

α=90.00°   β=94.481(2)°   γ=90.00°

5-(Pyridin-4-ylmethyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin- 4(5<i>H</i>)-one

C11H9N5O

Alsubari, AbdulsalamRamli, YoussefEssassi, El MokhtarZouihri, Hafid

Acta Crystallographica Section E (2011) 67, 8 o1926

a=4.6371(3)Å   b=19.2731(10)Å   c=5.8593(3)Å

α=90.00°   β=102.498(2)°   γ=90.00°

5-Acetyl-3-hydroxy-4-phenyl-4,5-dihydro-1<i>H</i>-1,5-benzodiazepin- 2(3<i>H</i>)-one

C17H16N2O3

Rida, MohamedAlsubari, AbdusalamEssassi, El MokhtarZouihri, HafidNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 12 o3337

a=8.97100(10)Å   b=9.31420(10)Å   c=9.41290(10)Å

α=81.5630(10)°   β=68.9210(10)°   γ=80.1460(10)°